Related Experiment Video
Updated: Jun 29, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Antiretroviral therapy during infancy: essential intervention for resource-limited settings
1Paediatric Infectious Diseases Unit, Red Cross Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Rondebosch, Cape Town, South Africa. brian.eley@uct.ac.za
Insights
Early treatment with highly active antiretroviral therapy (HAART) in HIV-infected African infants shows favorable short-term outcomes and high adherence rates. This supports current guidelines recommending prompt HAART initiation for all HIV-infected infants.
Area of Science:
- Pediatric infectious diseases
- Virology
- Global health
Background:
- Limited data exists on highly active antiretroviral therapy (HAART) outcomes in infants from low- and middle-income countries.
- Untreated HIV-infected infants under two years old represent a particularly vulnerable population.
- This study evaluates a randomized trial of immediate versus deferred HAART in 63 HIV-infected infants in a resource-poor setting.
Discussion:
- The study's findings align with recent global treatment guidelines advocating for early HAART initiation in all HIV-infected infants, regardless of clinical or immunological status.
- The favorable short-term outcomes and high adherence rates observed in both immediate and deferred HAART groups are critical considerations for resource-limited settings.
- The implications of these findings for public health policy and clinical practice in managing pediatric HIV in developing nations are significant.
Key Insights:
- Immediate HAART initiation in HIV-infected African infants demonstrated favorable short-term virological suppression.
- Deferred HAART initiation also yielded positive short-term outcomes, indicating potential flexibility in treatment timing.
- High adherence rates were observed in both treatment arms, suggesting feasibility of HAART management in resource-poor settings.
Outlook:
- Further research is needed to assess the long-term efficacy and safety of early HAART in this population.
- The findings support the integration of early infant diagnosis and prompt treatment into HIV/AIDS management programs in resource-limited settings.
- Continued monitoring and evaluation are essential to optimize pediatric HIV care strategies globally.
Abstract:
EVALUATION OF: Prendergast A, Mphatswe W, Tudor-Williams G et al. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS 22, 1333-1343 (2008). There is limited information regarding the outcome of infants treated with highly active antiretroviral therapy (HAART) in middle- and low-income countries. The mean/median age of children enrolled on HAART in these countries is generally high; however, it is acknowledged that untreated HIV-infected children under 2 years of age, including infected infants, are an extremely vulnerable group. This article assessed the findings of a recently published paper describing the outcome of 63 infants randomized to commence immediate or deferred HAART in a resource-poor setting and documented favorable short-term outcome in both groups, with correspondingly high adherence rates. The recent change in global treatment guidelines, recommending that all HIV-infected infants should be commenced on HAART soon after diagnosis, irrespective of their clinical status and/or immunological severity, is discussed in relation to the key findings of the article.
Related Concept Videos
Retrovirus Life Cycles
Respiratory Syncytial Virus Disease
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retroviruses
Inhibitors of Virion Maturation and Assembly
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

